Umasons Pharma Private Limited
Chemical manufacturing company established in 1996 with registered office in Jaipur, Rajasthan.
1996 | Jaipur, Rajasthan (India) | Active
Umasons Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 1.00 M
- Satisfied Charges ₹ 8.30 M
- Revenue Growth -19.83%
- Profit Growth -258.23%
- Ebitda 12.79%
- Net Worth -3.85%
- Total Assets -12.50%
About Umasons Pharma
Umasons Pharma Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 1996 and has a history of 28 years and seven months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹8.30 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Datwani and Harsha Datwani serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ1996PTC012282
- Company No.
012282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 1996
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Chemicals and Materials
Who are the key members and board of directors at Umasons Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Datwani  | Director | 02-Jul-1996 | Current |
| Harsha Datwani | Director | 18-Aug-2012 | Current |
Financial Performance of Umasons Pharma.
Umasons Pharma Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 19.83% decrease. The company also saw a substantial fall in profitability, with a 258.23% decrease in profit. The company's net worth dipped by a decrease of 3.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umasons Pharma?
In 2016, Umasons Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.00 M
Satisfied Charges
₹8.30 M
Charges Breakdown by Lending Institutions
- The Rajputana Mahila Urban Co-Op Bank Ltd : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2002 | The Rajputana Mahila Urban Co-Op Bank Ltd | ₹1.00 M | Open |
| 28 Jun 2002 | Uco Bank | ₹8.30 M | Satisfied |
How Many Employees Work at Umasons Pharma?
Unlock and access historical data on people associated with Umasons Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umasons Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umasons Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
